Estimaciones de analistas de Wall Street para Outlook Therapeutics, Inc. (OTLK): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 8 |
| Mantener | 6 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 14 |
| Calificación media (1-5) | 0.57 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-12-18 | $-0.06 | ||
| 2026-08-14 | $-0.09 | $-0.08 | -12.5% |
| 2026-05-15 | $-0.16 | $-0.12 | -33.3% |
| 2026-02-17 | $-0.22 | $-0.17 | -29.4% |
| 2025-12-19 | $-0.22 | $-0.23 | +4.3% |
| 2025-08-14 | $-0.44 | $-0.42 | -4.8% |
| 2025-05-15 | $-0.40 | $-0.55 | +27.3% |
| 2025-02-14 | $-0.89 | $-0.85 | -4.7% |
Ratios de valoración
| Precio / Valor contable | -1.60 |
| EV / EBITDA | -2.05 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $3.0M | $3.8M | $3.1M | $8.1M | 0 | 0 | 0 | 0 | 0 | $1.4M |
| Coste de Ventas | 0 | $23.8M | $18.5M | $23.8M | $554069 | 0 | $204694 | 0 | 0 | $756330 |
| Beneficio Bruto | 0 | 0 | 0 | -$15.7M | -$554069 | 0 | -$204694 | 0 | 0 | $657205 |
| I+D | $32.8M | $23.8M | $18.5M | $23.8M | $26.3M | $39.0M | $42.3M | $26.5M | $41.8M | $27.8M |
| Generales y Administrativos | $21.6M | $15.9M | $14.2M | $9.4M | $8.1M | $12.8M | $20.7M | $26.7M | $29.9M | $39.9M |
| Gastos Operativos | $21.6M | $39.7M | $32.7M | $44.4M | $34.4M | $51.7M | $62.9M | $53.1M | $71.7M | $67.7M |
| Beneficio Operativo | -$51.3M | -$35.9M | -$29.6M | -$36.3M | -$35.0M | -$51.7M | -$63.1M | -$53.1M | -$71.7M | -$67.1M |
| EBITDA | -$49.0M | -$30.0M | -$26.8M | -$31.1M | -$34.4M | -$52.0M | -$64.4M | -$56.4M | -$72.1M | -$63.6M |
| Gastos por Intereses | $1.9M | $5.6M | $3.9M | $3.5M | $1.8M | $936127 | $1.5M | $2.5M | $3.2M | $283128 |
| Beneficio Antes de Impuestos | -$53.2M | -$38.3M | -$33.7M | -$37.9M | -$38.5M | -$53.2M | -$66.0M | -$59.0M | -$75.4M | -$64.0M |
| Impuestos | $103000 | $501500 | -$3.6M | -$3.4M | -$3.3M | $2000 | $2800 | $2800 | $2800 | -$1.6M |
| Beneficio Neto | -$53.3M | -$38.8M | -$30.1M | -$34.5M | -$35.2M | -$53.2M | -$66.1M | -$59.0M | -$75.4M | -$62.4M |
| BPA | $-587.20 | $-267.20 | $-194.80 | $-39.60 | $-13.47 | $-7.00 | $-6.23 | $-4.80 | $-4.06 | $-1.79 |
| BPA Diluido | $-587.20 | $-288.00 | $-85.00 | $-39.60 | $-13.47 | $-7.00 | $-6.23 | $-4.80 | $-4.06 | $-1.79 |
| Acciones en Circulación (Diluidas) | $107581 | $150261 | $354026 | $909591 | $3.6M | $7.6M | $10.6M | $12.5M | $18.5M | $25.5M |
Precio
| Precio | $0.68 |
| Capitalización | $127M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: COEP · CUE · EQ · HOWL · IOBT · IPSC · MDCX
Explorar sector: Healthcare · Biotechnology
Más secciones de OTLK: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones